AI English summary of an SEC filing — figures as filed
International Flavors & Fragrances IFFIFF said reported sales for Q1 2025 were $2.84 billion, down 2% from the prior-year period, and that its loss before taxes was $(994) million and adjusted operating EBITDA was $578 million. The company cited an impairment of goodwill of $1.15 billion at Food Ingredients as reflected in the pre-tax loss.
Key points
AI summaryIFF said reported sales for Q1 2025 were $2.84 billion, down 2% from the prior-year period, and that its loss before taxes was $(994) million and adjusted operating EBITDA was $578 million. The company cited an impairment of goodwill of $1.15 billion at Food Ingredients as reflected in the pre-tax loss.
The company said cash flow from operations for Q1 2025 was $127 million, and free cash flow, defined as cash flow from operations less capital expenditures, was $(52) million. It said net debt to credit adjusted EBITDA was 3.9x at the end of Q1.
The company said Taste reported sales of $627 million for Q1, and comparable currency neutral sales rose 7%. Food Ingredients sales were $796 million, and comparable currency neutral sales fell 4%. The company cited lower demand in protein solutions as the primary factor.
The company said it is maintaining its full-year 2025 sales outlook of $10.6 billion to $10.9 billion and its adjusted operating EBITDA outlook of $2 billion to $2.15 billion. It said the Pharma Solutions divestiture closed on May 1, 2025, so the full-year outlook includes 4 months of Pharma Solutions results.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
IFF Reports Q1 2025 Sales, Pre-Tax Loss and Adjusted Operating EBITDA
IFF said reported sales for Q1 2025 were $2.84 billion, down 2% from the prior-year period, and that its loss before taxes was $(994) million and adjusted operating EBITDA was $578 million. The company cited an impairment of goodwill of $1.15 billion at Food Ingredients as reflected in the pre-tax loss.
Source · Based on the filing body and exhibits
Q1 Operating Cash Flow, Free Cash Flow and Net Debt Leverage
The company said cash flow from operations for Q1 2025 was $127 million, and free cash flow, defined as cash flow from operations less capital expenditures, was $(52) million. It said net debt to credit adjusted EBITDA was 3.9x at the end of Q1.
Source · Based on the filing body and exhibits
Taste and Food Ingredients Q1 Sales
The company said Taste reported sales of $627 million for Q1, and comparable currency neutral sales rose 7%. Food Ingredients sales were $796 million, and comparable currency neutral sales fell 4%. The company cited lower demand in protein solutions as the primary factor.
Source · Based on the filing body and exhibits
Full-Year Outlook Maintained, Including 4 Months of Pharma Solutions
The company said it is maintaining its full-year 2025 sales outlook of $10.6 billion to $10.9 billion and its adjusted operating EBITDA outlook of $2 billion to $2.15 billion. It said the Pharma Solutions divestiture closed on May 1, 2025, so the full-year outlook includes 4 months of Pharma Solutions results.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…